tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kevin Caliendo, 187 are a BUY (48.83%), 14 are a SELL (3.66%), 182 are a HOLD (47.52%).
Analyst Kevin Caliendo, currently employed at UBS, carries an average stock price target met ratio of 69.29% that have a potential upside of 18.72% achieved within 240 days. Previously, Kevin Caliendo worked at NEEDHAM.
Kevin Caliendo’s has documented 747 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on SOLV, Solventum Corp. at 14-May-2026.
Analyst best performing recommendations are on NVST (ENVISTA HOLDINGS CORP).
The best stock recommendation documented was for CVS (CVS HEALTH CORP) at 2/10/2025. The price target of $59 was fulfilled within 2 days with a profit of $6.7 (12.81%) receiving and performance score of 64.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Feb-2018
$215
$40.04 (22.89%)
$187
2 years 11 months 2 days ago
(07-Aug-2023)
15/16 (93.75%)
$28.91 (15.54%)
636
Hold Since 27-May-2022
$190
$15.04 (8.60%)
$176
2 years 11 months 6 days ago
(03-Aug-2023)
12/12 (100%)
$-0.86 (-0.45%)
392
Buy Since 11-Oct-2022
$215
$40.04 (22.89%)
$200
2 years 11 months 6 days ago
(03-Aug-2023)
7/10 (70%)
$24.14 (12.65%)
211
Buy Since 05-Aug-2021
$220
$45.04 (25.74%)
$213
2 years 11 months 6 days ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
$190
$15.04 (8.60%)
2 years 11 months 6 days ago
(03-Aug-2023)
9/9 (100%)
$-0.86 (-0.45%)
440
Which stock is Kevin Caliendo is most bullish on?
Which stock is Kevin Caliendo is most reserved on?
What Year was the first public recommendation made by Kevin Caliendo?
